A rare presentation of primary antiphospholipid syndrome

Panduranga Prashanth1, Mohammed Mukhaini, Abdulla Riyami

  • 1Department of Cardiology, Royal Hospital, Muscat, Sultanate of Oman.

Oman Medical Journal
|January 5, 2012
PubMed

Insights

Primary antiphospholipid syndrome caused a young patient to experience myocardial infarction and arterial thrombosis. This case highlights the link between antiphospholipid antibodies and coronary artery disease, offering insights into managing this rare condition.

Area of Science:

  • Cardiology
  • Rheumatology
  • Immunology

Background:

  • Primary antiphospholipid syndrome (APS) is an autoimmune disorder characterized by recurrent thrombotic events and pregnancy morbidity.
  • APS is associated with a hypercoagulable state due to antiphospholipid antibodies (aPLs).
  • While venous thrombosis is common in APS, arterial thrombosis, particularly coronary artery disease (CAD), is less frequent but carries significant morbidity.

Observation:

  • A young patient presented with myocardial infarction (MI).
  • In-situ thrombosis was identified in the left anterior descending coronary artery and the right common iliac artery.
  • The patient was diagnosed with primary antiphospholipid syndrome as the underlying cause.

Findings:

  • This case illustrates a rare presentation of primary APS leading to severe arterial thrombosis, including acute myocardial infarction.
  • The findings underscore the potential for antiphospholipid antibodies to directly contribute to the pathogenesis of coronary artery disease.
  • Management strategies for this rare condition involve anticoagulation and addressing underlying autoimmune mechanisms.

Implications:

  • This case emphasizes the importance of considering primary APS in young patients with unexplained arterial thrombosis and myocardial infarction.
  • Early diagnosis and aggressive management of aPL-associated cardiovascular events are crucial for improving patient outcomes.
  • Further research is warranted to elucidate the precise mechanisms linking aPLs to CAD and to optimize therapeutic approaches.

Related Concept Videos

Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
290
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
470
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
471
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
326
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
325
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
377